OrbusNeich Medical Group Holdings Ltd
HKEX:6929
Balance Sheet
Balance Sheet Decomposition
OrbusNeich Medical Group Holdings Ltd
OrbusNeich Medical Group Holdings Ltd
Balance Sheet
OrbusNeich Medical Group Holdings Ltd
| Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|
| Assets | ||||||
| Cash & Cash Equivalents |
15
|
176
|
87
|
58
|
60
|
|
| Cash |
0
|
0
|
87
|
58
|
60
|
|
| Cash Equivalents |
15
|
176
|
0
|
0
|
0
|
|
| Short-Term Investments |
0
|
0
|
161
|
198
|
189
|
|
| Total Receivables |
27
|
27
|
35
|
46
|
53
|
|
| Accounts Receivables |
26
|
27
|
32
|
38
|
42
|
|
| Other Receivables |
1
|
0
|
2
|
8
|
11
|
|
| Inventory |
30
|
30
|
29
|
41
|
56
|
|
| Other Current Assets |
2
|
3
|
2
|
4
|
4
|
|
| Total Current Assets |
74
|
235
|
314
|
348
|
361
|
|
| PP&E Net |
13
|
13
|
13
|
18
|
28
|
|
| PP&E Gross |
13
|
13
|
13
|
18
|
28
|
|
| Accumulated Depreciation |
21
|
22
|
23
|
24
|
25
|
|
| Intangible Assets |
4
|
4
|
4
|
10
|
10
|
|
| Goodwill |
2
|
2
|
2
|
13
|
10
|
|
| Long-Term Investments |
7
|
10
|
13
|
16
|
15
|
|
| Other Long-Term Assets |
4
|
4
|
5
|
6
|
7
|
|
| Other Assets |
2
|
2
|
2
|
13
|
10
|
|
| Total Assets |
104
N/A
|
269
+159%
|
351
+31%
|
410
+17%
|
431
+5%
|
|
| Liabilities | ||||||
| Accounts Payable |
1
|
2
|
4
|
5
|
7
|
|
| Accrued Liabilities |
10
|
10
|
14
|
12
|
13
|
|
| Short-Term Debt |
40
|
0
|
0
|
4
|
0
|
|
| Current Portion of Long-Term Debt |
1
|
1
|
2
|
2
|
2
|
|
| Other Current Liabilities |
3
|
3
|
4
|
13
|
9
|
|
| Total Current Liabilities |
55
|
16
|
24
|
36
|
31
|
|
| Long-Term Debt |
11
|
66
|
2
|
1
|
2
|
|
| Deferred Income Tax |
0
|
0
|
0
|
1
|
1
|
|
| Minority Interest |
0
|
0
|
0
|
1
|
1
|
|
| Other Liabilities |
3
|
3
|
2
|
3
|
3
|
|
| Total Liabilities |
69
N/A
|
85
+24%
|
28
-67%
|
42
+47%
|
38
-10%
|
|
| Equity | ||||||
| Common Stock |
0
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
44
|
198
|
62
|
108
|
149
|
|
| Additional Paid In Capital |
0
|
0
|
278
|
278
|
267
|
|
| Treasury Stock |
0
|
0
|
0
|
1
|
3
|
|
| Other Equity |
9
|
11
|
13
|
17
|
21
|
|
| Total Equity |
35
N/A
|
183
+425%
|
323
+76%
|
368
+14%
|
393
+7%
|
|
| Total Liabilities & Equity |
104
N/A
|
269
+159%
|
351
+31%
|
410
+17%
|
431
+5%
|
|
| Shares Outstanding | ||||||
| Common Shares Outstanding |
828
|
828
|
828
|
828
|
828
|
|